
Development and Roll-Out of A Coronavirus Disease 2019 Clinical Pathway for Standardized Qualified Care in Public Hospitals in Korea
Author(s) -
Mi Young Kwak,
Eun Young Jo,
Bum Sik Chin,
Se Eun Park,
Jun Yim,
Jung Eun Lee,
Kyung Eun Jo,
So Hyun Kim,
Jeong Eun Lee,
Young Kyung Yoon,
Yu Bin Seo,
Su Jin Jeong,
Yu Min Kang,
Eun-Jeong Joo,
Jong Hyun Yoon,
Sun Bean Kim,
Ga Yeon Kim,
Min-Kyung Kim
Publication year - 2022
Publication title -
infection and chemotherapy/gam'yeom gwa hwahag yo'beob/infection and chemotherapy
Language(s) - English
Resource type - Journals
eISSN - 2092-6448
pISSN - 1598-8112
DOI - 10.3947/ic.2022.0026
Subject(s) - medicine , covid-19 , outbreak , family medicine , quarantine , pandemic , disease , public health , coronavirus , public hospital , medical emergency , emergency medicine , nursing , virology , infectious disease (medical specialty) , pathology
Despite the coronavirus disease 2019 (COVID-19) vaccination roll-out, variant-related outbreaks have occurred repeatedly in Korea. Although public hospitals played a major role in COVID-19 patients' care, difficulty incorporating evolving COVID-19 treatment guidelines called for a clinical pathway (CP). Eighteen public hospitals volunteered, and a professional review board was created. CPs were formulated containing inclusion/exclusion criteria, application flow charts, and standardized order sets. After CP roll-out, key parameters improved, such as increased patient/staff five-point satisfaction scores (0.41/0.57) and decreased hospital stays (1.78 days)/medical expenses (17.5%). The CPs were updated consistently after roll-out as new therapeutics drugs were introduced and quarantine policies changed.